Invesaro

Stocks Health care PETV

OTC · Health care

PetVivo Holdings, Inc. (PETV)

PetVivo Holdings, Inc. brought in $1.2M of revenue over the twelve months to June 30, 2026, down 9.5% from a year earlier. It posted a net loss of $9.8M. In fiscal 2026 capital spending exceeded operating cash flow by $6.1M. At June 30, 2026 it held $122.6K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.

Watch PETV in 60 seconds
Price
$0.76
-9.52% on the day · September 28, 2026
52-week range $0.59 to $1.69
Market cap
$28.8M
Revenue (last 12 months)
$1.2M
-9.5% year on year
Net margin
-827.3%

What PetVivo Holdings, Inc. does

PetVivo Holdings, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on OTC under the ticker PETV.

Revenue and profit by year

Revenue
FY20: $3.6K $3.6K FY20FY21: $12.6K $12.6K FY21FY22: $115.6K $115.6K FY22FY23: $917.2K $917.2K FY23FY24: $968.7K $968.7K FY24FY25: $1.1M $1.1M FY25FY26: $1.1M $1.1M FY26
Net income
FY19: -$4.8M -$4.8M FY19FY20: -$2.1M -$2.1M FY20FY21: -$3.5M -$3.5M FY21FY22: -$5M -$5M FY22FY23: -$8.7M -$8.7M FY23FY24: -$11M -$11M FY24FY25: -$8.4M -$8.4M FY25FY26: -$10.5M -$10.5M FY26

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2026$1.1M-$9.1M-$10.5M-$0.38-$6.1M
2025$1.1M-$8.1M-$8.4M-$0.41-$5.4M
2024$968.7K-$10.6M-$11M-$0.78-$7.7M
2023$917.2K-$8.7M-$8.7M-$0.85-$7.2M
2022$115.6K-$5.1M-$5M-$0.57-$4.3M
2021$12.6K-$2M-$3.5M-$0.57-$907.9K

Full financial statements: income, balance sheet and cash flow

Next report expected around November 13, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 14, 2025. Not a date the company has announced. See the report calendar

Where PETV ranks in Health care

Revenue$1.1M
#636 of 742 in Health care · Bottom 14%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What PetVivo Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 22, 2026
  2. September 22, 2026
  3. September 15, 2026
  4. August 20, 2026
  5. August 14, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 13% to $337.6K versus the same quarter last year; diluted EPS -$0.05 versus -$0.10.
  6. August 5, 2026
  7. July 29, 2026
  8. July 27, 2026
  9. June 29, 2026
    Annual report 10-K · period to March 31, 2026Revenue rose 0.8% to $1.1M versus the prior year; diluted EPS -$0.38 versus -$0.41.
  10. June 25, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 21, 2026. Insider transactions on SEC

Insider trades

What the people running PetVivo Holdings, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders bought $40K worth of shares on the open market in the last 90 days and sold none.

Bought (open market)
$40K
last 90 days
Sold
$0
last 90 days
Net bought
58,602
$40K
DateInsiderWhatSharesPriceValueFiling
September 18, 2026 Rudelius Robert JamesDirector Received as pay 2,000 $0.72 $1.4K Form 4
September 18, 2026 Rudelius Robert JamesDirector Received as pay 1,497 $0.75 $1.1K Form 4
September 14, 2026 A.L. Sarroff Fund, LLC10% owner Bought 24,888 $0.69 $17.1K Form 4
September 10, 2026 A.L. Sarroff Fund, LLC10% owner Bought 10,974 $0.68 $7.4K Form 4
September 9, 2026 A.L. Sarroff Fund, LLC10% owner Boughtindirect 22,160 $0.68 $15K Form 4
September 9, 2026 Lai JohnChief Executive Officer, Director Received as pay 31,250 $0.80 $25K Form 4
September 9, 2026 Lai JohnChief Executive Officer, Director Received as pay 31,250 $0.78 $24.4K Form 4
September 8, 2026 Lowenthal Garry NChief Financial Officer Received as payindirect 31,250 $0.80 $25K Form 4
September 8, 2026 Lowenthal Garry NChief Financial Officer Received as payindirect 31,250 $0.80 $25K Form 4
August 27, 2026 A.L. Sarroff Fund, LLC10% owner Boughtindirect 580 $0.69 $398.5 Form 4
July 21, 2026 Lai JohnChief Executive Officer, Director Received as payindirect 75,000 $0.77 $57.8K Form 4
July 21, 2026 Lowenthal Garry NChief Financial Officer Received as payindirect 75,000 $0.77 $57.8K Form 4
June 9, 2026 A.L. Sarroff Fund, LLC10% owner Bought 187,500 - - Form 4
May 28, 2026 A.L. Sarroff Fund, LLC10% owner Gave as a gift 200,000 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns PETV

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
A.L. Sarroff Fund, LLC13D, may seek influence with 2 related filers 38.2% 16,940,839 September 15, 2026
Alexander Nazarenko13G, passive 18.73% 8,044,085 August 5, 2026
Cruden Stanley C13G, passive 9.4% 3,620,163 January 20, 2026

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

4 insiders reported holding 27,147,896 shares in total, about $20.6M at the last price.

HolderSharesAs of
A.L. Sarroff Fund, LLC10% owner 20,960,80010,462,469 held indirectly September 14, 2026
Lai JohnChief Executive Officer, Director 4,795,0762,381,913 held indirectly September 9, 2026
Lowenthal Garry NChief Financial Officer 985,131985,131 held indirectly September 8, 2026
Rudelius Robert JamesDirector 406,889 September 18, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about PETV

What does PetVivo Holdings, Inc. do?

PetVivo Holdings, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on OTC under the ticker PETV.

Is PetVivo Holdings, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $9.8M on revenue of $1.2M.

How much revenue does PetVivo Holdings, Inc. make?

Over the twelve months to June 30, 2026 PetVivo Holdings, Inc. reported revenue of $1.2M. That is 9.5% less than a year earlier.

When did PetVivo Holdings, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the executive or director change from September 22, 2026.

Similar companies

Compare PETV with

Compare PETV with any company

Follow PETV

Get an email when PetVivo Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow PETV: get an email when it files

Where the numbers come from

Financial figures are the values PetVivo Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.